1. INDICATIONS AND USAGE Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) Rheumatoid Arthritis (RA) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablet are indicated for relief of the signs and symptoms of rheumatoid arthritis.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 2006 | Original application | Approved | None posted |
| Nov 21, 2024 | Supplement 48Labeling · Standard review | Approved | None posted |
| May 10, 2024 | Supplement 44Labeling · Standard review | Approved | None posted |
| Oct 22, 2019 | Supplement 26Labeling · Standard review | Approved | None posted |
| Mar 2, 2015 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 13, 2013 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 31, 2011 | Supplement 11Labeling | Approved | None posted |
| Mar 3, 2011 | Supplement 9Labeling | Approved | None posted |
| Jan 21, 2009 | Supplement 2Labeling | Approved | None posted |
| Dec 20, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
